As the first company in Singapore to launch online supervised antigen rapid testing (ART) or tele-ART services in January, technology-led healthcare company Doctor Anywhere was quick to fill a need in the market.
With the launch, the unprecedented surge in demand for the service came as a surprise for founder and chief executive officer Lim Wai Mun and his team.
Using live data available on its platform, he could see that demand far outstripped what Doctor Anywhere could supply.
The astute businessman instantly knew that the firm had to rapidly scale up its resources to meet the demand, which was increasing day by day – which included hiring more medical staff, purchasing new laptops, and rapidly training tele-ART supervisors to keep up with the exponential demand.
“When I saw the live data, the urgency to scale up our operations became apparent. It was because we had this data, we were able to act on it quickly and grow the business,” he says.
Without this data, he believes they would not have been able to cope and get ahead of its competitors, which were rolling out the same service. As a result of his speedy action, Doctor Anywhere has since recorded close to 100,000 tele-ART transactions to date.
As a fast-growing regional healthcare company, there is a need for agility, efficiency, and visibility of its operations. Its tele-ART strategy marks precisely this nimbleness and readiness to quickly identify market opportunities and roll out new innovations to meet consumers’ needs.
Mr Lim recalls his original idea for Doctor Anywhere – to deliver medical aid without patients having to leave their homes – did not take off immediately. People were hesitant to entrust something as personal as healthcare to an online service provider. To overcome this, he knew they had to tap an “omni-channel” approach so the team set up physical clinics to provide a face-to-face presence where consumers could grow to know and trust the brand.